Clinical Trial

NAC for Hematopoietic Recovery in SAA

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective single-arm clinical study to evaluate the role of NAC among patients with severe aplastic anemia (SAA) can promote hematopoietic recovery after haploidentical transplantation.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06518044
Lead Sponsor Peking University People's Hospital
Conditions Aplastic Anemia
Enrollment 30 participants
Start Date 2024-07-25
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-24